Company intelligence / Profile preview

Inhalexpert

Ownership: Private
Development stage: Commercial

Overview

Inhalexpert provides consulting and hands-on leadership in the development of complex inhalation products, leveraging over 25 years’ experience in science, technology, manufacturing, and regulatory affairs. They offer Quality by Design (QbD) expertise for branded, bioequivalent/generic drugs as well as new chemical entities. The company forms strategic alliances to provide end-to-end formulation through approval but does not appear to have its own clinical-stage assets or published clinical results.

Modalities: Small molecule (inhaled)Biologic (inhaled)
Industry: Drug Discovery Services

Partnerships

APTYS Pharmaceuticals (strategic alliance for formulation/analytical/stability services)

Beyond the preview

Go deeper on Inhalexpert.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inhalexpert.

Explore the full profile